ES2628707T3 - Composición tópica potenciada - Google Patents

Composición tópica potenciada Download PDF

Info

Publication number
ES2628707T3
ES2628707T3 ES02778165.7T ES02778165T ES2628707T3 ES 2628707 T3 ES2628707 T3 ES 2628707T3 ES 02778165 T ES02778165 T ES 02778165T ES 2628707 T3 ES2628707 T3 ES 2628707T3
Authority
ES
Spain
Prior art keywords
agents
treatment
topical composition
active agent
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02778165.7T
Other languages
English (en)
Inventor
Jan Faergemann
Thomas Hedner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambria Dermatology AB
Original Assignee
Ambria Dermatology AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambria Dermatology AB filed Critical Ambria Dermatology AB
Application granted granted Critical
Publication of ES2628707T3 publication Critical patent/ES2628707T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición tópica que comprende del 15% en peso al 40% en peso de pentano-1,5-diol, un agente farmacológicamente activo, en el que el agente farmacológicamente activo se selecciona entre esteroides, agentes antimicóticos, antibióticos, agentes antivirales, antisépticos, agentes para el tratamiento del acné, agentes para el tratamiento de la psoriasis y eczema, así como otros agentes usados en el tratamiento de enfermedades que afectan a la piel, y un portador cosmética o farmacéuticamente aceptable, con la condición de que la composición no comprende polisiloxano, siloxano volátil, fosfatidilcolina, creatina, carnitina, pantenol, ácido pirúvico, monoglicérido de ácido láurico ni monoglicérido de ácido mirístico.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES02778165.7T 2001-10-21 2002-10-18 Composición tópica potenciada Expired - Lifetime ES2628707T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0103528A SE0103528D0 (sv) 2001-10-21 2001-10-21 Topiska kompositioner med förstärkt effekt
SE0103528 2001-10-21
PCT/SE2002/001908 WO2003035021A1 (en) 2001-10-21 2002-10-18 Potentiated topical composition

Publications (1)

Publication Number Publication Date
ES2628707T3 true ES2628707T3 (es) 2017-08-03

Family

ID=20285740

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02778165.7T Expired - Lifetime ES2628707T3 (es) 2001-10-21 2002-10-18 Composición tópica potenciada

Country Status (10)

Country Link
US (1) US8642053B2 (es)
EP (1) EP1446093B1 (es)
AU (1) AU2002339819B2 (es)
CA (1) CA2469474C (es)
DK (1) DK1446093T3 (es)
ES (1) ES2628707T3 (es)
NZ (1) NZ533087A (es)
RU (1) RU2295956C2 (es)
SE (1) SE0103528D0 (es)
WO (1) WO2003035021A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070093079A (ko) * 2004-11-29 2007-09-17 암브리아 더마톨로지 아베 적어도 세 개의 다른 디올을 포함하는 조성물
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
GB0912481D0 (en) * 2009-07-17 2009-08-26 Reckitt Benckiser Healthcare I Skincare compositions
RU2453305C1 (ru) * 2010-11-11 2012-06-20 Татьяна Владимировна Митрохина Лечебно-косметическое средство "белемнит" для лечения акне и псориаза
US20160243080A1 (en) * 2015-02-13 2016-08-25 Peter M. Abadir Formulations of angiotensin receptor blockers
JP6188855B1 (ja) * 2016-03-31 2017-08-30 大王製紙株式会社 ティシュペーパー
CN110809463B (zh) * 2017-09-28 2022-09-09 株式会社漫丹 半固体状清洗剂
RU2742964C2 (ru) * 2019-03-18 2021-02-12 Юрий Александрович Захаров Косметическая композиция
RU2731807C1 (ru) * 2020-05-05 2020-09-08 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт ревматологии имени В.А.Насоновой» (ФГБНУ НИИР им. В.А. Насоновой) Способ определения показаний к началу приема генно-инженерных биологических препаратов при неэффективности базисных противовоспалительных препаратов при ранних формах псориатического артрита

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979463A (en) * 1970-10-27 1976-09-07 Minnesota Mining And Manufacturing Company Fluoroaliphatic phenols
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
JPS5729213B2 (es) * 1974-11-12 1982-06-21
JPS572212A (en) * 1980-06-06 1982-01-07 Pola Chem Ind Inc Cosmetic
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
US4756906A (en) * 1986-03-18 1988-07-12 Minnesota Mining And Manufacturing Company Cosmetic colorant compositions
US5369129A (en) * 1989-06-13 1994-11-29 Hydro Pharma Ab Preparation of topical treatment of infections caused by virus, bacteria and fungi
US5641768A (en) * 1989-11-17 1997-06-24 Loria; Roger M. 5-androstene 3β, 17β diol for treatment
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
US5079003A (en) * 1990-03-14 1992-01-07 Adelia Scaffidi Skin lotions and creams
GB9010525D0 (en) * 1990-05-10 1990-07-04 Unilever Plc Cosmetic composition
DE4105345A1 (de) * 1991-02-21 1992-08-27 Kronos Int Inc Verfahren zur herstellung von feinteiligem titandioxid und feinteiliges titandioxid
WO1993003697A1 (en) 1991-08-27 1993-03-04 Cygnus Therapeutic Systems Transdermal formulations for administering prazosin
CA2123487A1 (en) * 1991-11-12 1993-05-27 Adrian S. Fox Adhesive hydrogels having extended use lives and process for the preparation of same
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
WO1995005137A1 (en) 1993-08-16 1995-02-23 Cygnus Therapeutic Systems Transdermal delivery system using a combination of permeation enhancers
EP0801941B1 (en) * 1995-11-22 2003-08-06 Shiseido Company, Ltd. Cosmetics
GR1002807B (el) * 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US5728732A (en) * 1996-11-27 1998-03-17 Elizabeth Arden Company, Division Of Conopco, Inc. Skin treatment with salicylic acid esters and retinoids
GB9626513D0 (en) 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
KR100508229B1 (ko) * 1997-03-18 2005-08-17 선스타 가부시키가이샤 고체 입자 형성용 조성물
BR9806128A (pt) * 1997-08-28 1999-08-31 Wella Ag Agente de cuidado de dois componentes
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
FR2785541B1 (fr) * 1998-11-09 2002-09-13 Oreal Systeme a activite antimicrobienne et son utilisation, notamment dans les domaines cosmetique et dermatologique
DE19857492A1 (de) * 1998-12-14 2000-06-15 Hans Lautenschlaeger Wasserhaltige Hautschutzpräparate zur Prävention von Hautschäden
DE19857491A1 (de) * 1998-12-14 2000-06-15 Hans Lautenschlaeger Hautschutzpräparate zur Prävention von Hautschäden mit UV-Filtern
CA2370633A1 (en) * 1999-04-29 2000-11-09 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
TR200100452T1 (tr) 1999-06-10 2001-07-23 Galat Alexander Deri yoluyla uygulanan aspirin
FR2794998B1 (fr) 1999-06-21 2001-07-27 Oreal Organogels et leurs utilisations notamment cosmetiques
US6548074B1 (en) * 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
US6649176B1 (en) * 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water

Also Published As

Publication number Publication date
US20040248993A1 (en) 2004-12-09
NZ533087A (en) 2005-12-23
CA2469474A1 (en) 2003-05-01
SE0103528D0 (sv) 2001-10-21
US8642053B2 (en) 2014-02-04
RU2004115747A (ru) 2005-04-10
AU2002339819B2 (en) 2007-03-15
RU2295956C2 (ru) 2007-03-27
CA2469474C (en) 2014-04-15
EP1446093A1 (en) 2004-08-18
DK1446093T3 (en) 2017-07-03
WO2003035021A1 (en) 2003-05-01
EP1446093B1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
HK1085390A1 (en) Solution for ungual and peri-ungual application and its use in preparation of a medicament treating dermatological diseases
ES2703505T3 (es) Combinación de adapaleno y peróxido de benzoilo para tratar lesiones de acné
ES2103506T3 (es) Utilizacion de acidos hidroxicarboxilicos y sus derivados para la preparacion de composiciones dermatologicas topicas para el tratamiento de arrugas.
ES2109899T1 (es) Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos.
AR039335A1 (es) Tableta de carga de droga alta
ES2628707T3 (es) Composición tópica potenciada
BR0107869A (pt) Composições farmacêuticas eletrogiradas
AR059113A1 (es) Composicion para administracion topica
FR2887150B1 (fr) Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
AR001790A1 (es) Formulaciones para parches transdermicos que sirven para el tratamiento de condiciones modeladas de receptores muscarinicos
CO2022003583A2 (es) Compuestos de curcumina y aminoácidos básicos
CO5540370A2 (es) Comprimido que comprende cetirizina y pseudoefredina
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
ES2129448T3 (es) Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas.
AR054361A1 (es) Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas
BR0210063A (pt) Composição estável e uso da mesma
ES2113136T3 (es) Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion.
ATE328569T1 (de) Wasserfreie schweisshemende oder desodorierende zusammensetzungen enthaltend einen festen, wasserlöslichen hautpflegenden wirkstoff und glycerin
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes
RU2008115908A (ru) Фармацевтическая композиция, содержащая гиалуронидазу и липосомы для наружного применения
RU2007132165A (ru) Адапален для длительного лечения обыкновенных угрей
AR045178A1 (es) Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica
RU2012134159A (ru) Средство для лечения ран и ожогов
PE20011092A1 (es) Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel